---
figid: PMC7476343__10.1177_1076029620954282-fig1
figtitle: Representation of the reciprocal links between cancer and thrombosis
organisms:
- NA
pmcid: PMC7476343
filename: 10.1177_1076029620954282-fig1.jpg
figlink: pmc/articles/PMC7476343/figure/fig1-1076029620954282/
number: F1
caption: 'Representation of the reciprocal links between cancer and thrombosis. Tumor
  cells can express procoagulant factors, such as tissue factor (TF), that trigger
  the cascade of coagulation, which would be suppressed by mechanisms that induce
  endothelial tissue factor pathway inhibitors (TFPI). Tumor cells interact with endothelial
  cells, platelets, and leukocytes and these interactions induce inflammatory cytokines
  and pro-angiogenic factors such as vascular endothelial growth factor (VEGF). Neutrophil
  attraction contributes to the accumulation of neutrophil extracellular traps (NETs)
  and triggers adhesion, activation, and generation of thrombin. In general, the adherence
  of cancer to the endothelium causes the release of procoagulants and formation of
  thrombus, leading to CAT occurrence. TF also triggers the generation of factor VIIa,
  factor Xa, and thrombin (IIa), which activate platelets and induce protease-activated
  receptor-mediated signaling. The plasminogen activator (PA) system is expressed
  on platelets and it consists of plasminogen activators: urokinase plasminogen activator
  (uPA), tissue plasminogen activator (tPA), cell membrane receptor for uPA (uPAR),
  and the plasminogen activator inhibitors plasminogen activator inhibitor 1 (PAI-1)
  and plasmin. The PA system has an effect on cell adhesion and migration, which is
  particularly important in cancer progression. Also, TF suppress vasculoprotective
  molecules, such as thrombomodulin (TM). Release of von willebrand factor (VWF) promotes
  recruitment, adhesion, and activation of platelets and leukocytes with formation
  of NETs. abbreviations: APC, activated protein C; GAGS, glycosaminoglycans heparin
  sulfate; PC, protein C; PCI, protein C inhibitor; TNF, tumor necrosis factor-alpha.'
papertitle: 'Cancer-Associated Thrombosis: Risk Factors, Molecular Mechanisms, Future
  Management.'
reftext: Marwa S. Hamza, et al. Clin Appl Thromb Hemost. 2020 Jan-Dec;26:1076029620954282.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9665128
figid_alias: PMC7476343__F1
figtype: Figure
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
redirect_from: /figures/PMC7476343__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7476343__10.1177_1076029620954282-fig1.html
  '@type': Dataset
  description: 'Representation of the reciprocal links between cancer and thrombosis.
    Tumor cells can express procoagulant factors, such as tissue factor (TF), that
    trigger the cascade of coagulation, which would be suppressed by mechanisms that
    induce endothelial tissue factor pathway inhibitors (TFPI). Tumor cells interact
    with endothelial cells, platelets, and leukocytes and these interactions induce
    inflammatory cytokines and pro-angiogenic factors such as vascular endothelial
    growth factor (VEGF). Neutrophil attraction contributes to the accumulation of
    neutrophil extracellular traps (NETs) and triggers adhesion, activation, and generation
    of thrombin. In general, the adherence of cancer to the endothelium causes the
    release of procoagulants and formation of thrombus, leading to CAT occurrence.
    TF also triggers the generation of factor VIIa, factor Xa, and thrombin (IIa),
    which activate platelets and induce protease-activated receptor-mediated signaling.
    The plasminogen activator (PA) system is expressed on platelets and it consists
    of plasminogen activators: urokinase plasminogen activator (uPA), tissue plasminogen
    activator (tPA), cell membrane receptor for uPA (uPAR), and the plasminogen activator
    inhibitors plasminogen activator inhibitor 1 (PAI-1) and plasmin. The PA system
    has an effect on cell adhesion and migration, which is particularly important
    in cancer progression. Also, TF suppress vasculoprotective molecules, such as
    thrombomodulin (TM). Release of von willebrand factor (VWF) promotes recruitment,
    adhesion, and activation of platelets and leukocytes with formation of NETs. abbreviations:
    APC, activated protein C; GAGS, glycosaminoglycans heparin sulfate; PC, protein
    C; PCI, protein C inhibitor; TNF, tumor necrosis factor-alpha.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ac
  - Cat
  - Ca-alpha1T
  - ChAT
  - sv
  - Va
  - Apc
  - Apc2
  - Axn
  - Fs(3)Apc
  - Pc
  - Ets97D
  - tf
  - upd1
  - vi
  - Sh
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
  - Tep1
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - FGA
  - FGB
  - FGG
  - TFF3
  - TFPI
  - CAT
  - CRAT
  - GLYAT
  - SERPINA5
  - APC
  - PROC
  - PC
  - HADHA
  - PLAT
  - SERPINE1
  - PLAUR
  - TF
  - PLAU
  - PRAP1
  - VWF
---
